POSITION STATEMENT : MOUNJARO WEIGHT LOSS INJECTIONS
POSITION STATEMENT: MOUNJARO (TIRZEPATIDE) FOR MANAGING WEIGHT LOSS AND OBESITY
Who is eligible?
The first group of people eligible under the national criteria includes individuals who:
• Have a Body Mass Index (BMI) of 40 kg/m² or more (or 37.5 kg/m² for people from minority ethnic family backgrounds)
And have at least four of the following long-term conditions:
• Non-diabetic hyperglycaemia or type two diabetes
• Hypertension (high blood pressure)
• Dyslipidaemia
• Established cardiovascular disease
• Obstructive sleep apnoea (formally diagnosed)
Please refer to the guidance attached for more information.